Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Corbus Pharmaceuticals Inc.

Clinical trials sponsored by Corbus Pharmaceuticals Inc., explained in plain language.

Corbus Pharmaceuticals Inc. CRBP NASDAQ

Develops treatments for inflammatory and fibrotic diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1

New obesity drug CRB-913 enters human testing

Disease control Ongoing

This study tests a new drug called CRB-913 for weight loss in people with obesity. It involves 252 participants and has two parts: first, measuring how the drug works in healthy adults, then comparing three doses against a placebo over 12 weeks. The goal is to check safety and ho…

Phase: PHASE1 • Sponsor: Corbus Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC